Speakers
Science 37
Speaker TBC
Day Two
Thursday, September 9, 2021
9:50 am | Science 37 Presentation
10:20 am | Morning Q&A & Panel Forum
Datacubed Health
Speaker TBC
Day Two
Thursday, September 9, 2021
12:45 pm | Lunchtime Q&A & Panel Forum
John Reites
Chief Executive Officer
THREAD Research
Day One
Wednesday, September 8, 2021
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
Ricki Fairley
Chief Executive Officer
TOUCH, The Black Breast Cancer Alliance
Tony Fantana
Lead, Emerging Technology Strategy - Clinical Design, Delivery and Analytics
Eli Lilly and Company
Brendan Mcsheffrey
President
Consent Custody Corporation
Joel Morse
Chief Executive Officer
Curavit
Maria Harrison
Senior Vice President, Decentralized Clinical Trials and Real World Solutions
ICON
Day Two
Thursday, September 9, 2021
10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs
Isaac Rodriguez-Chavez
Senior Vice President of Scientific & Clinical Affairs
ICON
Day One
Wednesday, September 8, 2021
10:25 am | Morning Q&A and Panel Forum
9:50 am | Innovation & High Impact on Patients’ Health Journey: Integrating Decentralized Clinical Trials (DCTs) with Clinical Research as a Care Option (CRAACO)
8:45 am | Chair’s Opening Remarks
Steven R. Cummings
Executive Director, San Francisco Coordinating Center
California Pacific Medical Center Research Institute
Day One
Wednesday, September 8, 2021
5:25 pm | Chair’s Closing Remarks
3:05 pm | Afternoon Q&A Panel Forum
2:10 pm | Removing Complexity: The Art of Cutting Tethers to the Trial Site
Amir Lahav
Digital Healthcare Innovation, Head of Digital R&D
Mitsubishi Tanabe Pharma Holding America
Day Two
Thursday, September 9, 2021
3:25 pm | Panel: Too Hybrid, or Not to Hybridize?
10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs
10:20 am | Morning Q&A & Panel Forum
9:00 am | Keynote: New Trends in Remote Digital Monitoring Technology for Decentralized Trials in Patients with Neurodegenerative Diseases
8:50 am | Chair’s Opening Remarks
Tracey Robertson
Global Clinical Development & Operations – Head of Patient & Site Engagement Process
Boehringer Ingelheim
Day One
Wednesday, September 8, 2021
5:05 pm | Closing Q&A & Panel Forum
4:40 pm | Designing a Hybrid Trial to Support Patient Choice
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
Day Two
Thursday, September 9, 2021
4:10 pm | Chair’s Closing Remarks
10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs
Rachel Chasse
Director of Innovation
Digital Medicine Society (DiMe)
Day One
Wednesday, September 8, 2021
10:25 am | Morning Q&A and Panel Forum
9:25 am | DiMe on DCTs: Your How-To Guide
Daniel R Karlin, MD, MA
Chief Medical Officer
MindMed
Day Two
Thursday, September 9, 2021
3:25 pm | Panel: Too Hybrid, or Not to Hybridize?
3:10 pm | Afternoon Q&A & Panel Forum
1:55 pm | DCTs as Agile Clinical Experiments to Develop Novel Methods
Arturo Loaiza-Bonilla
Enterprise Director of Research
Cancer Treatment Centers of America
Day One
Wednesday, September 8, 2021
5:05 pm | Closing Q&A & Panel Forum
4:15 pm | Best Strategies to Optimize Patient Enrolment & Health Care Provider Engagement in the Digital Era: A Case Study
Mary C. Birmingham, PharmD
Director, Clinical Scientist
Janssen Scientific Affairs LLC
Day One
Wednesday, September 8, 2021
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
10:25 am | Morning Q&A and Panel Forum
9:00 am | Execution of a Randomized Decentralized Clinical Trial - a J&J Case Study
Rebecca Jackson
Clinical R&D SME - Clinical Data IT, Clinical Trials, Clinical Supply Chain
Johnson & Johnson
Day Two
Thursday, September 9, 2021
10:20 am | Morning Q&A & Panel Forum
9:25 am | Exploring the IMI Trials@Home Initiative
Jim Ternyila
Senior Business Relationship Manager - Digital Therapeutics
AstraZeneca
Day Two
Thursday, September 9, 2021
12:45 pm | Lunchtime Q&A & Panel Forum
12:05 pm | Using Vendors: What to Ask Them and What to Look For?
Amy Bohn
Director, DCT Operations DCT Strategy & Implementation
Bayer
Day One
Wednesday, September 8, 2021
1:00 pm | Midday Q&A panel
12:10 pm | Evaluating Clinical Trials for a Decentralized Approach
Day Two
Thursday, September 9, 2021
3:25 pm | Panel: Too Hybrid, or Not to Hybridize?
Erica Lawson
Director, Applied Innovation
Otsuka
Day Two
Thursday, September 9, 2021
10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs
Arthur Combs, MD
President
FutureTech Strategies, Inc.
Day Two
Thursday, September 9, 2021
3:25 pm | Panel: Too Hybrid, or Not to Hybridize?
Craig Lipset
Co-Chair
Decentralized Trials & Research Alliance (DTRA)
Day Two
Thursday, September 9, 2021
3:10 pm | Afternoon Q&A & Panel Forum
2:20 pm | Collaboration to Accelerate the Global Adoption of Decentralized Trials
Jim Hacunda
R&D Digital Strategy Lead
Takeda
Day One
Wednesday, September 8, 2021
3:05 pm | Afternoon Q&A Panel Forum
2:50 pm | Using Systems Modelling to Compare & Contrast Centralized vs Decentralized Clinical Trials
Vera Rulon
Founder and President
Tir Health Advisors
Ruth Schneider, MD
Assistant Professor of Neurology
University of Rochester
Day Two
Thursday, September 9, 2021
3:10 pm | Afternoon Q&A & Panel Forum
2:45 pm | Lessons from Observational, Remote Research Studies in Neurodegenerative Diseases
Gunilla Andrew-Nielsen
Head of Department of Clinical Trials and Special Permissions
Medical Products Agency
Day One
Wednesday, September 8, 2021
5:05 pm | Closing Q&A & Panel Forum
3:25 pm | Case Studies from Running Patient Centric Clinical Trials Supported by Remote & Virtual Elements
Jen Horonjeff
Founder & CEO
Savvy Cooperative
Day One
Wednesday, September 8, 2021
5:05 pm | Closing Q&A & Panel Forum
3:50 pm | Some ‘Savvy’ Solutions to Providing Your Patients with Choice in a Decentralized Clinical Trial
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
Brandon Maggio
Director of Digital & Process Optimization
GSK
Day One
Wednesday, September 8, 2021
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
Shoibal Datta
Head, R&D Digital Strategy Group, Data Sciences Institute
Takeda
Day Two
Thursday, September 9, 2021